ABL-mediated SOS1 phosphorylation promotes RAC activation, contributing to leukemogenic effects driven by BCR–ABL, thereby underscoring the noteworthy role of SOS1 in CML progression (32, 58). The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.